Sodium-glucose transport: role in diabetes mellitus and potential clinical implications - PubMed (original) (raw)

Review

Sodium-glucose transport: role in diabetes mellitus and potential clinical implications

Volker Vallon et al. Curr Opin Nephrol Hypertens. 2010 Sep.

Abstract

Purpose of review: Current options for glycemic control are less than optimal in terms of efficacy and to reduce complications in the diabetic population. Selective inhibition of SGLT2 in the proximal tubule increases urinary glucose excretion thereby reducing plasma glucose levels, which may present a novel therapeutic approach.

Recent findings: SGLT2 inhibitors enhance glucose excretion and improve glycemic control in patients with type 2 diabetes in the absence of clinically relevant hypoglycemia or sustained changes in volume status or glomerular filtration rate. This is associated with lowering of body weight and may reduce systolic blood pressure. The increased glucosuria appears to increase the risk of genital infections but may not increase the risk of urinary tract infections.

Summary: The ability of SGLT2 inhibitors to reduce plasma glucose without inducing increased insulin secretion, clinically relevant hypoglycemia, or weight gain constitutes a major advance. The ability to increase glucose excretion provides a powerful means to treat caloric excess conditions. Important questions remain to be resolved and more clinical research is needed on the long-term effects of SGLT2 inhibition. Potential extrarenal effects need to be explored in order to determine the safety of these compounds. It also remains to be determined whether these drugs lower the toxicity of glucose directly on renal cells, independent of hyperglycemia, which may slow or prevent the progressive nature of diabetic nephropathy.

PubMed Disclaimer

Cited by

Na(+)-D-glucose cotransporter SGLT1 is pivotal for intestinal glucose absorption and glucose-dependent incretin secretion.
Gorboulev V, Schürmann A, Vallon V, Kipp H, Jaschke A, Klessen D, Friedrich A, Scherneck S, Rieg T, Cunard R, Veyhl-Wichmann M, Srinivasan A, Balen D, Breljak D, Rexhepaj R, Parker HE, Gribble FM, Reimann F, Lang F, Wiese S, Sabolic I, Sendtner M, Koepsell H. Gorboulev V, et al. Diabetes. 2012 Jan;61(1):187-96. doi: 10.2337/db11-1029. Epub 2011 Nov 28. Diabetes. 2012. PMID: 22124465 Free PMC article.
Sodium-retaining effect of insulin in diabetes.
Brands MW, Manhiani MM. Brands MW, et al. Am J Physiol Regul Integr Comp Physiol. 2012 Dec;303(11):R1101-9. doi: 10.1152/ajpregu.00390.2012. Epub 2012 Oct 3. Am J Physiol Regul Integr Comp Physiol. 2012. PMID: 23034715 Free PMC article. Review.
Inhibition of kidney proximal tubular glucose reabsorption does not prevent against diabetic nephropathy in type 1 diabetic eNOS knockout mice.
Gangadharan Komala M, Gross S, Mudaliar H, Huang C, Pegg K, Mather A, Shen S, Pollock CA, Panchapakesan U. Gangadharan Komala M, et al. PLoS One. 2014 Nov 4;9(11):e108994. doi: 10.1371/journal.pone.0108994. eCollection 2014. PLoS One. 2014. PMID: 25369239 Free PMC article.
Aquaporin 11 insufficiency modulates kidney susceptibility to oxidative stress.
Atochina-Vasserman EN, Biktasova A, Abramova E, Cheng DS, Polosukhin VV, Tanjore H, Takahashi S, Sonoda H, Foye L, Venkov C, Ryzhov SV, Novitskiy S, Shlonimskaya N, Ikeda M, Blackwell TS, Lawson WE, Gow AJ, Harris RC, Dikov MM, Tchekneva EE. Atochina-Vasserman EN, et al. Am J Physiol Renal Physiol. 2013 May 15;304(10):F1295-307. doi: 10.1152/ajprenal.00344.2012. Epub 2013 Mar 13. Am J Physiol Renal Physiol. 2013. PMID: 23486012 Free PMC article.
Pathophysiology of the diabetic kidney.
Vallon V, Komers R. Vallon V, et al. Compr Physiol. 2011 Jul;1(3):1175-232. doi: 10.1002/cphy.c100049. Compr Physiol. 2011. PMID: 23733640 Free PMC article. Review.

References

1. Wright EM, Turk E. The sodium/glucose cotransport family SLC5. Pflugers Arch. 2004;447:510–518. - PubMed
1. You G, Lee WS, Barros EJ, et al. Molecular characteristics of Na(+)-coupled glucose transporters in adult and embryonic rat kidney. J Biol Chem. 1995;270:29365–29371. - PubMed
1. Wright EM. Renal Na(+)-glucose cotransporters. Am J Physiol Renal Physiol. 2001;280:F10–F18. - PubMed
1. Kanai Y, Lee WS, You G, et al. The human kidney low affinity Na+/glucose cotransporter SGLT2. Delineation of the major renal reabsorptive mechanism for D-glucose J Clin Invest. 1994;93:397–404. - PMC - PubMed
1. Wood IS, Trayhurn P. Glucose transporters (GLUT and SGLT): expanded families of sugar transport proteins. Br J Nutr. 2003;89:3–9. - PubMed

Sodium-glucose transport: role in diabetes mellitus and potential clinical implications - PubMed (original) (raw)